The Sexually Transmitted Diseases Diagnostics Market is expected to escalate at a CAGR of 7.9%, from USD 3.8 billion in 2022 to USD 6.4 billion through 2032.The COVID-19 pandemic is a global health threat unmatched by anything that has occurred before, and its impact on sexually transmitted diseases testing is expec...